First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation

A. Secchi, S. Martinenghi, R. Caldara, E. La Rocca, V. Di Carlo, G. Pozza

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In this study we have investigated blood glucose and serum free insulin response to glucose and to arginine orally or intravenously, 3 months and 3 years after a successful segmental, neoprene-injected, pancreas transplantation. Serum insulin responses to different secretagogues were normal 3 months after transplantation; they remained normal up to 3 years after transplantation.

Original languageEnglish
JournalDiabetologia
Volume34
Issue number1 Supplement
DOIs
Publication statusPublished - Aug 1991

Fingerprint

Pancreas Transplantation
Arginine
Neoprene
Transplantation
Insulin
Glucose
Serum
Blood Glucose

Keywords

  • arginine test
  • intravenous glucose tolerance test
  • oral glucose tolerance test
  • Pancreas transplantation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation. / Secchi, A.; Martinenghi, S.; Caldara, R.; La Rocca, E.; Di Carlo, V.; Pozza, G.

In: Diabetologia, Vol. 34, No. 1 Supplement, 08.1991.

Research output: Contribution to journalArticle

Secchi, A. ; Martinenghi, S. ; Caldara, R. ; La Rocca, E. ; Di Carlo, V. ; Pozza, G. / First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation. In: Diabetologia. 1991 ; Vol. 34, No. 1 Supplement.
@article{917607a021da441c99dba58af5110332,
title = "First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation",
abstract = "In this study we have investigated blood glucose and serum free insulin response to glucose and to arginine orally or intravenously, 3 months and 3 years after a successful segmental, neoprene-injected, pancreas transplantation. Serum insulin responses to different secretagogues were normal 3 months after transplantation; they remained normal up to 3 years after transplantation.",
keywords = "arginine test, intravenous glucose tolerance test, oral glucose tolerance test, Pancreas transplantation",
author = "A. Secchi and S. Martinenghi and R. Caldara and {La Rocca}, E. and {Di Carlo}, V. and G. Pozza",
year = "1991",
month = "8",
doi = "10.1007/BF00587620",
language = "English",
volume = "34",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "1 Supplement",

}

TY - JOUR

T1 - First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation

AU - Secchi, A.

AU - Martinenghi, S.

AU - Caldara, R.

AU - La Rocca, E.

AU - Di Carlo, V.

AU - Pozza, G.

PY - 1991/8

Y1 - 1991/8

N2 - In this study we have investigated blood glucose and serum free insulin response to glucose and to arginine orally or intravenously, 3 months and 3 years after a successful segmental, neoprene-injected, pancreas transplantation. Serum insulin responses to different secretagogues were normal 3 months after transplantation; they remained normal up to 3 years after transplantation.

AB - In this study we have investigated blood glucose and serum free insulin response to glucose and to arginine orally or intravenously, 3 months and 3 years after a successful segmental, neoprene-injected, pancreas transplantation. Serum insulin responses to different secretagogues were normal 3 months after transplantation; they remained normal up to 3 years after transplantation.

KW - arginine test

KW - intravenous glucose tolerance test

KW - oral glucose tolerance test

KW - Pancreas transplantation

UR - http://www.scopus.com/inward/record.url?scp=0025866372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025866372&partnerID=8YFLogxK

U2 - 10.1007/BF00587620

DO - 10.1007/BF00587620

M3 - Article

C2 - 1936696

AN - SCOPUS:0025866372

VL - 34

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 1 Supplement

ER -